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DObjective: Few recent studies have assessed the epidemiology of and risk factors for surgical site infections
(SSIs) and bloodstream infections (BSIs) in infants after cardiac surgery. We hypothesized that infants younger
than 30 days old and those with higher Risk Adjustment in Congenital Heart Surgery-1 scores would have an
increased risk of SSIs, but not an increased risk of BSIs after surgery.
Methods:We performed a retrospective cohort study of infants younger than 1 year of age undergoing cardiac
surgery from January 2010 to December 2011 to determine the rates of SSIs and BSIs occurring within 3 months
of surgery, risk factors associated with these infections, and causative pathogens. Multivariable associations
using Cox proportional hazard modeling assessed potential risk factors for BSIs or SSIs.
Results: Overall, 8.7% (48 of 552) of surgical procedures were complicated by SSIs (n¼ 19) or BSIs (n¼ 29).
Thus, SSIs and BSIs occurred after 3.4% and 5.3% of procedures, respectively. Multivariate models found age
younger than 30 days, incorrect timing of preoperative antibiotics, and excessive bleeding within 24 hours of
surgery to be significant predictors for SSIs, and duration of use of arterial lines to be a significant predictor
for BSIs. Gram-positive bacteria caused 75% of SSIs and BSIs and methicillin-susceptible Staphylococcus
aureus caused 63% of SSIs.
Discussion: We identified some potential strategies to reduce risk, including closer monitoring of timing of
preoperative antimicrobial prophylaxis and enhanced efforts to achieve intraoperative hemostasis and earlier
removal of arterial lines.
Conclusions: SSIs and BSIs remain important complications after cardiac surgery in infants. (J Thorac
Cardiovasc Surg 2014;148:259-65)C
HApproximately 20,000 pediatric patients, of whom 50% are
infants younger than 1 year of age, undergo reparative and
palliative procedures for structural heart defects in the
United States each year.1 Surgical site infections (SSIs)
and postoperative bloodstream infections (BSIs) are well-
described complications of cardiac surgery and can occur
in 3% to 8% and 6% to 10% of children, respectively.2-6
Furthermore, the mortality rate can increase 2-fold after
SSIs and 3-fold after BSIs and both infections are associ-
ated with an increased length of hospital stay, readmissions,
and higher health care expenditures.7,8
When compared with older children, infants younger
than 1 year of age are at increased risk of postoperative
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The Journal of Thoracic and Caknowledge, no recent studies have described the
epidemiology of these health care–associated infections
(HAIs) in this age group or identified potentially
modifiable risk factors to prevent such infections. The
objectives of this study were to determine the incidence
of SSIs and BSIs after cardiac surgery in infants, risk
factors for such infections, the causative pathogens, and
their susceptibility to antimicrobial agents. Potential
preoperative, intraoperative, and postoperative risk factors
including adherence to selected perioperative prophylaxis
recommendations used at our institution were assessed.
We hypothesized that infants younger than 30 days of age
and those with higher Risk Adjustment in Congenital
Heart Surgery 1 (RACHS-1) scores11 would be at increased
risk of SSIs, but not at increased risk of BSIs.METHODS
Study Design, Site, and Subjects
We performed a retrospective cohort study of infants younger than 1
year of age who underwent cardiac surgery at our tertiary care, academic
children’s hospital in New York City from January 2010 to December
2011. At our hospital, children older than a month of age generally receive
postoperative care in the pediatric cardiac intensive care unit (14 beds) and
neonates 1 month or younger generally receive care in the cardiac area of
the neonatal intensive care unit (12 beds). Eligible infants were those
undergoing either palliative or definitive repair of complex congenitalrdiovascular Surgery c Volume 148, Number 1 259
Abbreviations and Acronyms
BSI ¼ bloodstream infection
CI ¼ confidence interval
CLABSI ¼ central line–associated bloodstream
infection
HAI ¼ health care–associated infection
RACHS-1 ¼ Risk Adjustment in Congenital Heart
Surgery 1
RBC ¼ red blood cell
SSI ¼ surgical site infection
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Dcardiac lesions. Excluded infants were those undergoing cardiac transplan-
tation or pacemaker implantation only, or premature infants undergoing
ligation of a patent ductus arteriosus. The Columbia University Medical
Center Institutional Review Board granted a waiver of informed consent
for this study.
SSIs and BSIs
To determine the rate of SSIs or BSIs, the clinical courses of eligible
infants were followed up for 90 days after each cardiac procedure. If an
eligible infant had more than one cardiac procedure during the study
period, all procedures were included to determine these rates. The Centers
for Disease Control and Prevention’s National Healthcare Safety Network
case definitions were used for SSIs, primary and secondary BSIs, and
central line–associated bloodstream infections (CLABSIs).12 In addition,
the causative pathogens and their susceptibility to cefazolin were assessed
using the Clinical and Laboratory Standards Institute guidance.13
Risk Factors for SSIs and BSIs
The electronic health records of eligible infants were reviewed for
potential risk factors for BSIs or SSIs. If an infant had more than one
surgical procedure during their first year of life, risk factors were assessed
only after the first procedure. Potential risk factors included demographic
characteristics (eg, age at the time of surgery, sex), comorbid conditions
(eg, chromosomal anomalies or lack of splenic function), as well as
preoperative factors (eg, duration of preoperative hospitalization, American
Society of Anesthesiologists, and RACHS-1 category). The American
Society of Anesthesiologists score correlates physical status with surgical
mortality14; a score of 1 indicates an otherwise healthy patient and a score
of 5 indicates a patient not expected to live more than 24 hours independent
of a surgical intervention. TheRACHS-1 categories combine cardiac surgical
procedures that have similar surgicalmortality rates; group1procedures carry
the lowest risk of mortality and group 6 procedures carry the highest risk of
mortality.11 In addition, intraoperative factors (eg, skin disinfection with
povidone-iodine vs chlorhexidine; duration of cardiopulmonary bypass,
aortic cross-clamp, and deep hypothermic circulatory arrest), and postopera-
tive factors (eg, excessive bleeding defined as receiving red blood cells
(RBCs) plus 2 or more of the following products: platelets, fresh-frozen
plasma, and/or factor VII within 24 hours of surgery end time; and duration
of device use such as central venous catheters and chest tubes) were assessed.
Furthermore, failure to provide the correct perioperative prophylactic
antibiotic (ie, cefazolin, or vancomycin if allergic to b-lactam agents or his-
tory of infection or colonization with methicillin-resistant Staphylococcus
aureus) or incorrect timing (ie, failure to administer cefazolin within 60
minutes or vancomycin within 120 minutes before incision) was assessed.
Statistical Methods
The incidence of postoperative BSIs and SSIs was determined. Bivariate
associations between potential risk factors and BSIs or SSIs after the first
surgical procedurewere examined using Cox proportional hazardmodeling260 The Journal of Thoracic and Cardiovascular Surg(version 9.2 for Windows; SAS Institute, Inc, Cary, NC). Kaplan-Meier
survival curves were plotted to test the proportionality assumption of the
models. Infants were censored for HAIs, death, or 90 days after their last
surgical procedure. The hazard ratio, 95% confidence interval (CI), and
P value were reported for each potential risk factor.
Significant variables (P<.05) from the bivariate analysis were included
in the multivariable Cox proportional hazards saturated model. In addition,
the RACHS-1 score was included in the multivariable model to test the
hypothesis that a higher RACHS-1 score was a risk factor for SSI. Infants
with missing values for one or more of the significant bivariate variables
were excluded from the multivariable analysis. The final model for each
outcome was determined by backward elimination. Variables in the final
model were selected based on the stability of the model (lower Akaike
information criterion) and either remained significant predictors
(P< .05) or potential confounders (>10% difference in the parameter
estimate). Colinearity and multilinearity were tested when appropriate. If
variables were found to be collinear or multilinear, then the potentially
more biologically relevant parameter was selected for the multivariable
model (eg, because weight and age were found to be collinear [r ¼ 0.81;
n ¼ 470; P<.0001], age was selected). If both continuous and categoric
parameters were significant for a given variable (eg, age and neonate),
the categoric parameter (ie, neonate defined as age<30 days at the time
of surgery) was included in the multivariate analysis.RESULTS
During the study period, 504 infants underwent 602
cardiac procedures, of whom 470 infants (552 procedures)
were included in this study. The following infants were
excluded: those undergoing patent ductus arteriorus ligation
procedures (n¼ 26), heart transplantation (n¼ 12), or pace-
maker implantation (N ¼ 11), and 1 infant who died within
24 hours of surgery. Among the 470 included infants, 401,
58, 10, and 1 infant had 1, 2, 3, and 4 cardiac procedures,
respectively, performed during their first year of life.Incidence of BSI and SSI
After the 552 included surgical procedures, 19 SSIs
occurred (1 deep and 18 superficial SSIs) and 29 BSIs (6
CLABSIs) occurred. Thus, the rates of SSIs and BSIs in
the study population were 3.4% and 5.3%, respectively.
No subject had both a BSI and SSI. After the 207 procedures
performed in neonates younger than 30 days of age, the
rates of SSIs and BSIs were 6.8% (n ¼ 14) and 3.9%
(n¼ 8), respectively. SSIs presented a mean of 27 days after
surgery (median, 19 days; range, 9-49 days) and BSIs pre-
sented a mean of 17 days after surgery (median, 9 days;
range, 1-76 days).Risk Factors Associated With HAIs
All SSIs and 69% (20 of 29) of BSIs occurred after the
first surgical procedure and thus were included in the risk
factor analyses shown in Table 1 (SSIs) and in Table 2
(BSIs). Bivariate analysis identified 6 potential risk factors
for SSIs and 4 potential risk factors for BSIs. Younger age,
non-white race, lower weight, higher intraoperative glucose
level, excessive bleeding, and incorrect timing of pre-
operative antibiotics were associated positively with SSIs.ery c July 2014
TABLE 1. Risk factors for surgical site infections after cardiac surgery in infants: Bivariate analysis
Characteristics SSI (N ¼ 19) (%) No SSI (N ¼ 451) (%) Crude HR (95% CI) P value
Demographics
Age, mean (d) 26.3 79.2 0.99 (0.97-1.00) .02
Age,<1 mo 16 (84) 343 (64) 3.87 (1.39-10.75) .01
Male 12 (63) 251 (56) 1.37 (0.54-3.48) .51
Premature,<37 wk 5 (26) 94 (21) 1.00 (0.40-2.46) 1.00
Race, white (n,%) 5 (26) 233 (52) 0.34 (0.12-0.94) .04
Hispanic 1 (5) 44 (10) 0.51 (0.07-3.80) .51
Weight, mean (kg) 2.94 4.15 0.61 (0.43-0.85) <.01
Preoperative factors
Hospitalized before surgery (n,%) 16 (84) 295 (65) 2.89 (0.84-9.91) .09
Prior length of stay, mean (d) 11.1 8.77 1.01 (0.99-1.02) .61
Comorbidities
Noncardiac anomaly 7 (37) 127 (28) 1.46 (0.57-3.70) .43
Chromosomal anomaly* 4 (21) 82 (18) 1.16 (0.39-3.50) .79
DiGeorge syndrome 2 (50) 19 (23) 3.40 (0.48-24.12) .22
Trisomy 21 1 (25) 31 (38) 0.54 (0.06-5.12) .59
Absence of splenic function 1 (5) 11 (2) 2.33 (0.31-17.49) .41
American Society of Anesthesiologists score
3 5 (26) 197 (44) Reference
>3 14 (74) 254 (56) 2.15 (0.77-5.96) .14
RACHS-1 score
1 and 2 10 (53) 223 (49) Reference
3 9 (47) 228 (51) 0.84 (0.34-2.08) .37
Skin preparation 17 (89) 394 (87) 1.23 (0.29-5.33) .78
Chlorhexidine gluconate 0 (0) 102 (23) — —
Povidone-iodine 16 (84) 290 (64) 2.97 (0.87-10.19) .08
Intraoperative factors
Length of procedure,>180 min 12 (63) 215 (48) 1.88 (0.74-4.77) .19
Cardiac re-operation 0 (0) 27 (6) — —
Cardiopulmonary bypass (n,%) 14 (74) 312 (69) 0.82 (0.33-2.05) .66
Cardiopulmonary bypass, mean (min) 99.4 88.7 1.00 (1.00-1.01) .54
Aortic cross-clamp (n,%) 12 (63) 305 (68) 0.89 (0.36-2.23) .81
Aortic cross-clamp, mean (min) 48.8 49.0 1.00 (0.99-1.01) .98
Circulatory arrest (n,%) 6 (32) 97 (22) 1.55 (0.60-4.04) .37
Circulatory arrest, mean (min) 19.1 11.2 1.00 (1.00-1.01) .53
Highest glucose level, mean (mg/dL)y 208.3 166.4 1.01 (1.00-1.02) .01
Lowest temperature, mean (C)z 26.8 28.5 1.00 (1.00-1.00) .73
<20C 6 (33) 90 (21) 1.64 (0.41-6.56) .48
20C-28C 3 (17) 75 (17) 0.99 (0.20-4.89) .97
28C-35C 6 (33) 197 (45) 0.76 (0.19-3.04) .70
>35C 3 (17) 73 (17) Reference
Last temperature in operating room recorded, mean (C) 37.0 35.7 1.00 (1.00-1.00) .77
Sternotomy (n,%) 17 (89) 355 (79) 2.26 (0.52-9.78) .28
Steroids administered (n,%) 12 (63) 253 (56) 1.34 (0.53-3.40) .54
Excessive bleeding 4 (21) 14 (3) 7.87 (2.59-23.56) <.01
Postoperative factors
Delayed sternal closure 3 (16) 35 (8) 2.10 (0.61-7.20) .24
Device days, mean
Chest tubes 5.32 3.76 1.04 (0.99-1.09) .15
Mechanical ventilation 4.89 2.92 1.04 (1.00-1.09) .08
Pacing wires 5.58 5.58 1.00 (0.99-1.01) .99
Central venous lines 8.24 6.80 1.01 (0.98-1.04) .60
Arterial lines 4.74 3.59 1.02 (0.97-1.07) .43
Exogenous blood transfusion 9 (53) 284 (63) 1.47 (0.60-3.62) .40
Next day glucose level, mean (mg/dL) 148.8 133.8 1.00 (1.00-1.01) .29
(Continued)
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TABLE 1. Continued
Characteristics SSI (N ¼ 19) (%) No SSI (N ¼ 451) (%) Crude HR (95% CI) P value
Preoperative antibiotic prophylaxis
Incorrect drug 1 (5) 30 (7) 0.79 (0.11-5.93) .82
Incorrect timing 6 (32) 63 (14) 2.80 (1.06-7.36) .04
Bold indicatesP values<.05. SSI, Surgical site infection;HR, hazard ratio;CI, confidence interval; RACHS-1, Risk Adjustment in Congenital Heart Surgery 1. *Eighty-six infants
underwent chromosomal analysis. yEighty-three procedures were excluded because no intraoperative glucose recording was available. zSeventeen procedures were excluded
because no intraoperative temperature record was available.
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mechanical ventilation, longer use of arterial lines,
and the incorrect preoperative prophylactic agent were
associated with BSIs.
In the final multivariate model, risk factors for SSIs
included age younger than 30 days (HR, 4.45; 95% CI,
1.21-16.39; P ¼ .02), incorrect timing of preoperative
antibiotics (HR, 3.65; 95% CI, 1.33-10.02; P ¼ .01), and
excessive blood loss within 24 hours of surgery (HR,
4.72; 95% CI, 1.46-15.29; P¼ .01). In addition, the highest
intraoperative glucose level remained in the model; high
glucose level was a significant confounder and was
associated with 13.2% difference in the parameter estimate
for neonates younger than 30 days old. In the final multi-
variate model, the risk factor for BSIs was the duration of
arterial line use (HR, 1.04/d; 95% CI, 1.01-1.07;
P ¼ .005). In addition, the incorrect preoperative prophy-
lactic agent remained in the model; this was a significant
confounder and was associated with 19.1% difference in
the parameter estimate for the duration of arterial lines.
Pathogens Causing SSI and BSI
Most HAIs (75%) were caused by Gram-positive bacte-
ria (Tables 3 and 4). Methicillin-susceptible S aureus
caused 63% of SSIs and coagulase-negative staphylococci
caused 58% of BSIs. Six polymicrobial BSIs occurred and
no polymicrobial SSIs occurred. Although 68% of the
pathogens associated with SSIs were susceptible to
cefazolin, only 7% of BSIs were susceptible to this agent.
DISCUSSION
To our knowledge, this was the largest study in the
modern era assessing the epidemiology of selected HAIs
in infants younger than 1 year of age undergoing cardiac
surgery. We focused on this population because younger
age, lower weight, and younger gestational age have been
described previously as risk factors for SSIs and BSIs and
we wanted to expand our understanding of the risks in
this unique population, including potentially modifiable
factors.2,4,6,9,15-18 Overall, 8.7% of procedures were
complicated by either a BSI or SSI. SSIs complicated
3.4% of procedures and the majority (18 of 19) were
superficial. BSIs complicated 5.3% of procedures and the
minority were CLABSIs (6 of 29).12 Notably, in the current
study, most (87%) infants had a central line and we262 The Journal of Thoracic and Cardiovascular Surgspeculate that our insertion and maintenance bundle
policies to reduce CLABSIs may have favorably affected
this outcome.
We did confirm our hypothesis that neonates younger
than 30 days of age are at increased risk of SSIs, presumably
because the neonate is at increased risk of infection. Similar
findings have been noted by others because neonates had a
2-fold increased risk of infection when compared with older
infants and children.9,15,18 However, RACH-1 scores were
not predictive of SSIs. Similarly, others have not found
that the severity of the cardiac lesion was associated with
SSIs.4,15
We also found that inappropriate preoperative timing and
higher intraoperative glucose level (mean, 208 mg/dL) were
risk factors for SSIs. Although pediatric perioperative
guidelines for SSI prevention are unavailable, appropriate
timing has been associated with a reduction in SSIs in adult
patients and is a key component of the Surgical Care
Improvement Project sponsored by the Centers for Medi-
care and Medicaid.19,20 Although intraoperative glucose
levels have not been found to be a risk factor for SSIs in
adult patients, higher postoperative glucose levels are a
risk factor.21 Glucose control (defined as <200 mg/dL)
the day after cardiac surgery is advocated as a measure to
reduce SSIs.22 The biological explanation for the associa-
tion between increased glucose level and SSIs is uncertain.
Hyperglycemia, even acute short-term hyperglycemia, can
affect immune function. When exposed to hyperglycemia,
neutrophils show decreased chemotaxis, impaired phagocy-
tosis, and reduced production of reactive oxygen species. In
addition, hyperglycemia is associated with reduced micro-
vascular reactivity and impaired complement function.23
Excessive blood loss within 24 hours after surgery also
was associated with SSIs. Several studies have found an
association between RBC transfusions and postcardiac
surgical infections in both adults and children.24-27 It has
been hypothesized that the age of the transfused RBCs is
responsible for this association28,29; because RBCs age,
non–transferrin-bound serum iron increases,30 which is
thought to have a direct impact on host immune cells and/or
increase bacterial virulence.31
In our population we did not confirm the findings of others
that have implicated length of surgery9,17; duration of
cardiopulmonary bypass, aortic cross-clamp, and
circulatory arrest4,16; hypothermia15; and delayed sternalery c July 2014
TABLE 2. Risk factors for bloodstream infection after cardiac surgery in infants: Bivariate analysis
Characteristics BSI (N ¼ 20) (%) No BSI (N ¼ 450) (%) Crude HR (95% CI) P value
Demographic characteristics
Age, mean (d) 72.8 77.3 1.00 (0.99-1.01) .78
Age,<1 mo 8 (40) 192 (43) 0.917 (0.38-2.24) .28
Sex, male (n,%) 13 (65) 250 (56) 1.48 (0.59-3.71) .40
Premature,<37 wk (n,%) 5 (25) 94 (21) 1.26 (0.46-3.46) .66
Race, white (n,%) 7 (35) 231 (51) 0.51 (0.21-1.29) .15
Hispanic (n,%) 0 (0) 45 (10) — —
Weight, mean (kg) 4.04 4.10 0.98 (0.76-1.25) .98
Preoperative factors
Hospitalized before surgery (n,%) 20 (100) 291 (65) — —
Prior length of stay, mean (d) 12.6 8.70 1.01 (0.99-1.02) .39
Comorbidities (n,%)
Noncardiac anomaly 6 (30) 128 (28) 1.07 (0.41-2.80) .88
Chromosomal anomaly* 3 (15) 83 (18) 0.78 (0.23-2.65) .78
DiGeorge syndrome 2 (67) 19 (23) 6.86 (0.62-75.7) .12
Trisomy 21 1 (33) 31 (37) 0.81 (0.07-8.97) .49
Absence of splenic function 2 (10) 10 (2) 4.62 (1.07-19.9) .04
American Society of Anesthesiologists score
3 7 (35) 195 (43) Reference
>3 13 (65) 255 (57) 1.41 (0.57-3.56) .46
RACHS-1 score (n,%)
1 and 2 9 (45) 224 (50) Reference
3 11 (55) 226 (50) 1.20 (0.50-2.90) .68
Skin preparation (n,%) 18 (90) 393 (87) 1.30 (0.30-5.59) .73
Chlorhexidine gluconate 2 (10) 100 (22) 0.39 (0.09-1.66) .20
Povidone-iodine 16 (80) 290 (64) 2.21 (0.74-6.61) .16
Intraoperative factors
Procedure length>180 min (n,%) 11 (55) 216 (48) 1.33 (0.55-3.20) .53
Cardiac re-operation (n,%) 2 (10) 25 (6) 1.84 (0.43-7.94) .41
Cardiopulmonary bypass (n,%) 13 (65) 313 (70) 0.82 (0.33-2.05) .66
Cardiopulmonary bypass, mean (min) 81.2 89.5 1.00 (0.99-1.01) .63
Aortic cross-clamp (n,%) 13 (65) 304 (68) 0.89 (0.36-2.23) .81
Aortic cross-clamp, mean (min) 36.1 49.5 0.99 (0.98-1.01) .26
Circulatory arrest (n,%) 6 (30) 97 (22) 1.55 (0.60-4.04) .37
Circulatory arrest, mean (min) 13.5 11.4 1.00 (0.99-1.01) .86
Highest glucose level, mean (mg/dL)y 150.3 168.9 0.99 (0.98-1.00) .25
Lowest temperature, mean (C)z 28.9 28.5 1.00 (1.00-1.00) .73
<20C 4 (21) 92 (21) 1.07 (0.24-4.80) .93
20C-28C 2 (11) 76 (18) 0.65 (0.11-3.91) .64
28C-35C 10 (53) 193 (44) 1.26 (0.35-4.57) .73
>35C 3 (16) 73 (17) Reference
Last temperature in operating room recorded, mean (C) 36.0 35.8 1.00 (1.00-1.00) .82
Sternotomy (n,%) 15 (75) 357 (79) 0.79 (0.29-2.18) .65
Steroids administered (n,%) 10 (50) 255 (57) 0.78 (0.32-1.87) .57
Excessive bleeding 1 (5) 17 (4) 1.47 (0.20-11.0) .71
Postoperative factors
Delayed sternal closure 2 (10) 36 (8) 1.26 (0.29-5.42) .76
Device days, mean
Chest tubes 4.85 3.78 1.03 (0.97-1.09) .30
Mechanical ventilation 5.75 2.87 1.05 (1.01-1.09) .01
Pacing wires 8.50 5.45 1.00 (0.99-1.01) .73
Central venous lines 9.19 6.71 1.02 (0.99-1.04) .23
Arterial lines 9.05 3.40 1.05 (1.02-1.08) <.001
Exogenous blood transfusion (n,%) 12 (60) 281 (62) 1.05 (0.18-6.30) .96
Next day glucose level, mean (mg/dL) 160.6 134.8 1.00 (1.00-1.01) .38
(Continued)
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TABLE 2. Continued
Characteristics BSI (N ¼ 20) (%) No BSI (N ¼ 450) (%) Crude HR (95% CI) P value
Preoperative antibiotic prophylaxis
Incorrect drug 4 (20) 27 (6) 3.54 (1.18-10.60) .02
Incorrect timing 4 (20) 65 (14) 1.50 (0.50-4.48) .47
Bold indicates P values<.05. BSI, Bloodstream infection; HR, hazard ratio; CI, confidence interval; RACHS-1, Risk Adjustment in Congenital Heart Surgery 1. *Eighty-six
infants underwent chromosomal analysis. yEighty-three procedures were excluded because no intraoperative glucose recording was available. zSeventeen procedures were
excluded because no intraoperative temperature record was available.
TABLE 4. Pathogens causing BSIs after cardiac surgery in infants
Microorganism
BSIs (n ¼ 29)
N %
Gram-positive
Staphylococcus epidermidis 10 34
Staphylococcus hominis 6 21
Congenital Heart Disease Murray et al
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Dclosure as risk factors for SSIs.2-4,17,18 Although the
explanation for our different findings is uncertain, previous
studies were performed in adults and older children. In
general, infants undergoing cardiac surgery have a more
high-risk surgery characterized by longer bypass time,
longer cross-clamp time, and deep hypothermia, which
may confound comparisons with previous studies.
As predicted, risk factors for BSIs found in the multi-
variable analysis were different than those associated with
SSIs because only the duration of use of arterial lines
proved to be a risk factor in this population. Prolonged
use of arterial lines suggests a portal of entry for potential
pathogens causing BSIs. Prior hospitalization, prior cardiac
surgery, and prolonged ventilation have been associated
with colonization with potential pathogens, and, in
adult patients, daily bathing with chlorhexidine gluconate
can reduce the risk of HAIs.32 Previous studies have
found that prolonged preoperative hospitalization,3,4,16
associated noncardiac or chromosomal anomalies
including heterotaxy and asplenia/polysplenia,4,16 prior
cardiac surgery,18 and mechanical ventilation4,16 were
associated with an increased risk of BSIs. Although an
absence of splenic function, mechanical ventilation, and
arterial lines were risk factors for BSIs in the bivariate
analysis, it is feasible that our small sample size
precluded finding these associations in the multivariable
models.
The majority of SSIs were caused by methicillin-
susceptible S aureus. Data in adults have suggested that
cefazolin should be administered within 60 minutes before
surgical incision to ensure optimal concentrations in the
skin. Subtherapeutic levels of cefazolin in the skin mayTABLE 3. Pathogens causing SSIs after cardiac surgery in infants
Microorganism
SSIs (n ¼ 19)
n %
Gram-positive
Methicillin-sensitive S aureus 12 63
Methicillin-resistant S aureus 2 11
Corynebacterium sp 1 5
Enterococcus faecalis 1 5
Gram-negative
Escherichia coli 1 5
No growth 2 11
SSIs, Surgical site infections.
264 The Journal of Thoracic and Cardiovascular Surgresult from conventional dosing used in obese individuals.
Intraoperative redosing may be needed to maintain skin
and serum levels.33 We speculate that the concentration of
cefazolin achieved by our 30-mg/kg/dose regimen may be
too low for this population, particularly given blood loss,
nearly universal intraoperative transfusions in infants
weighing less than 15 kg, and the volume of blood in the
cardiopulmonary bypass circuit. Pharmacokinetic studies
are needed in young infants to address this concern.
This study had several limitations. It was a single-center
study, the sample size was relatively small, and infectious
outcomes were relatively few. These factors limit the
generalizability of this study. Some SSIs may have been
missed because infants were only followed up for 3 months.
We think this is unlikely because all SSIs in this study
occurred fewer than 60 days after surgery. Notably, in
2013, the Centers for Disease Control and Prevention’s
National Healthcare Safety Network changed the duration
of follow-up evaluation for deep and organ space SSIs
from 1 year to 90 days.34 Some infants with SSIs may
have presented at other institutions after discharge.
However, we believe this is unlikely given the close
follow-up evaluation of infants with congenital heart
disease after discharge. We did not collect the location
of arterial lines or the volume of chest tube output orStaphylococcus capitis 1 3
E faecalis 2 7
Streptococcus mitis 1 3
Gram-negative
Klebsiella pneumoniae 5 17
Klebsiella oxytoca 2 7
Enterobacter cloacae 1 3
Enterobacter aerogenes 1 3
Serratia marcescens 3 10
E coli 2 7
Yeast
Candida albicans 1 3
Polymicrobial 6 21
BSIs, Bloodstream infections.
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Murray et al Congenital Heart Diseasetransfusion volumes associated with excessive bleeding. In
addition, there were missing data that could have affected
the results because those procedures were excluded from
the analysis.
In conclusion, SSIs and BSIs remain complications of
cardiac surgery in infants. We identified some potentially
modifiable risk factors including closer monitoring of
intraoperative glucose levels, enhanced efforts to facilitate
earlier extubation and arterial line removal, and attention
to intraoperative hemostasis. Our study suggests possible
future investigations for this vulnerable population
including assessment of the contribution of other peri-
operative prophylaxis parameters such as intraoperative
redosing, decreasing the age of transfused RBCs, the role
of routine skin disinfection postoperatively, and strategies
to improve cefazolin pharmacokinetics.C
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